市場調查報告書

新型冠狀病毒感染疾病 (COVID-19) 診斷的全球市場:2020-2026年

COVID-19 Diagnostics Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 949649
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
新型冠狀病毒感染疾病 (COVID-19) 診斷的全球市場:2020-2026年 COVID-19 Diagnostics Market 2020-2026
出版日期: 2020年06月27日內容資訊: 英文
簡介

全球新型冠狀病毒感染疾病 (COVID-19) 診斷的市場在預測期間記錄大幅度的成長。感染者數的劇增與其伴隨的迅速診斷、檢驗數的增加,PCR技術相關技術迅速的發展等要素預計促進該市場成長。可是同時,設備及套件的高價格性可能妨礙在預測期間內的進一步成長。

本報告提供全球新型冠狀病毒感染疾病 (COVID-19) 診斷的市場調查,市場定義和概要,市場成長的各種影響因素分析,相關法律,市場規模的變化、預測,類型、技術、終端用戶等各種區分的明細,各地區、主要國家的詳細分析,競爭環境,企業佔有率,主要企業簡介等資訊彙整。

第1章 報告概要

第2章 市場概要、考察

  • 調查範圍
  • 分析師的見解、目前市場趨勢
  • 法律規章

第3章 競爭情形

  • 企業佔有率分析
  • 主要策略分析
  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近的發展

第4章 市場影響因素

  • 成長推動因素
  • 阻礙成長要素
  • 市場機會

第5章 市場分析、預測:各種區分

  • 各類型
    • 設備
    • 試劑、套件
  • 各技術
    • PCR
    • 抗體、ELISA
    • 血清
    • 其他
  • 各終端用戶
    • 醫院
    • 診斷中心、緊急醫療診所
    • 研究機關

第6章 市場分析、預測:各地區、主要國家

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第7章 企業簡介

  • Abbott Laboratories Inc.
  • ADT Biotech Sdn Bhd
  • Altona Diagnostics GmBH
  • Beckman Coulter Inc.
  • biomerieux SA
  • Cellex Inc.
  • Cepheid Inc.
  • Chembio Diagnostic Systems Inc.
  • Epitope Diagnostics, Inc.
  • F. Hoffman-La Roche Ltd.
  • Hologic Inc.
  • Laboratory Corp. of America Holdings
  • Luminex Corp.
  • Mylab Discovery Solutions Pvt Ltd.
  • PerkinElmer, Inc.
  • Quidel Corp.
  • Seegene Inc.
  • SureScreen Diagnostics Ltd.
  • Thermo Fisher Scientific Inc.
  • Veredus Laboratories
目錄
Product Code: OMR2021968

Global COVID-19 Diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments and Reagents & Kits), By Technology (Polymerase Chain Reaction (PCR), Antibody or Enzyme-Linked Immunosorbent Assay (ELISA), Serology, and Others), By End-User (Hospitals, Diagnostic Centers & Urgent Care Clinics, Research Labs), and Forecast 2020-2026

The global COVID-19 diagnostics market is estimated to register significant growth over the forecast period 2020-2026. The primary factors that drive the market growth include the upsurge in the cases of COVID-19 cases along with the rapid diagnosis and tests going on, to prevent the spread across the globe. Further, the rapid enhancements in the technology along with the use of PCR technology in the detection of the virus is encouraging market growth during the forecast period. However, the higher prices of the devices and kits are likely to hamper the market growth during the forecast period.

The global COVID-19 diagnostic market is segmented on the basis of type, technology, and end-user. Based on the type, the market is bifurcated into instruments and reagents & kits. The reagents & kits segment is projected to grow significantly over the forecast period. Based on the technology, the market is segmented into polymerase chain reaction (PCR), antibody or enzyme-linked immunosorbent assay (ELISA), serology, and others such as portable or point-of-care testing. ELISA segment is projected to grow significantly over the forecast period. Based on the end-user, the market is sectioned into hospitals, diagnostic centers & urgent care clinics, research labs. The hospital segment is projected to grow significantly over the forecast period.

Geographically, the study of the global COVID-19 diagnostic market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World.

Further, Abbott Laboratories Inc., biomerieux SA, Cellex Inc., Cepheid Inc., F. Hoffman-La Roche AG, Laboratory Corp. of America Holdings, Luminex Corp., PerkinElmer Inc., Mylab Discovery Solutions Pvt Ltd., Thermo Fisher Scientific Inc. among others are some of the prominent players functioning in the global COVID-19 diagnostics market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players to sustain in the highly competitive market.

Research Methodology

The market study of the global COVID-19 diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for medical device companies, pharmaceutical companies, research institutes, academic institutes, potential investors, government organizations, regulatory authorities, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. Global COVID-19 Diagnostics Market Research and Analysis by Type

2. Global COVID-19 Diagnostics Market Research and Analysis by Technology

3. Global COVID-19 Diagnostics Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of the global COVID-19 diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global COVID-19 diagnostics market.
  • Insights about market determinants which are stimulating the global COVID-19 diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of the market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Key Strategy Analysis
  • 3.2. Key Company Analysis
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints/Challenges
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global COVID-19 Diagnostics Market by Type
    • 5.1.1. Instruments
    • 5.1.2. Reagents & Kits
  • 5.2. Global COVID-19 Diagnostics Market by Technology
    • 5.2.1. Polymerase Chain Reaction (PCR)
    • 5.2.2. Antibody or Enzyme-Linked Immunosorbent Assay (ELISA)
    • 5.2.3. Serology
    • 5.2.4. Others
  • 5.3. Global COVID-19 Diagnostics Market by END-USER
    • 5.3.1. Hospitals
    • 5.3.2. Diagnostic Centers & Urgent Care Clinics
    • 5.3.3. Research Labs

6. By Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories Inc.
  • 7.2. ADT Biotech Sdn Bhd
  • 7.3. Altona Diagnostics GmBH
  • 7.4. Beckman Coulter Inc.
  • 7.5. biomerieux SA
  • 7.6. Cellex Inc.
  • 7.7. Cepheid Inc.
  • 7.8. Chembio Diagnostic Systems Inc.
  • 7.9. Epitope Diagnostics, Inc.
  • 7.10. F. Hoffman-La Roche Ltd.
  • 7.11. Hologic Inc.
  • 7.12. Laboratory Corp. of America Holdings
  • 7.13. Luminex Corp.
  • 7.14. Mylab Discovery Solutions Pvt Ltd.
  • 7.15. PerkinElmer, Inc.
  • 7.16. Quidel Corp.
  • 7.17. Seegene Inc.
  • 7.18. SureScreen Diagnostics Ltd.
  • 7.19. Thermo Fisher Scientific Inc.
  • 7.20. Veredus Laboratories

LIST OF TABLES

  • 1. GLOBAL COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 2. GLOBAL COVID-19 DIAGNOSTICS INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL COVID-19 DIAGNOSTICS REAGENTS & KITS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 4. GLOBAL COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2019-2026 ($ MILLION)
  • 5. GLOBAL POLYMERASE CHAIN REACTION (PCR) FOR COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 6. GLOBAL ANTIBODY OR ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) FOR COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 7. GLOBAL SEROLOGY FOR COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 8. GLOBAL OTHER TECHNOLOGIES FOR COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 9. GLOBAL COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 10. GLOBAL COVID-19 DIAGNOSTICS IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 11. GLOBAL COVID-19 DIAGNOSTICS IN DIAGNOSTIC CENTERS & URGENT CARE CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 12. GLOBAL COVID-19 DIAGNOSTICS IN RESEARCH LABS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 13. GLOBAL COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
  • 14. NORTH AMERICAN COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 15. NORTH AMERICAN COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 16. NORTH AMERICAN COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2019-2026 ($ MILLION)
  • 17. NORTH AMERICAN COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 18. EUROPEAN COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 19. EUROPEAN COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 20. EUROPEAN COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2019-2026 ($ MILLION)
  • 21. EUROPEAN COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 22. ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 23. ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 24. ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2019-2026 ($ MILLION)
  • 25. ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)
  • 26. REST OF THE WORLD COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 27. REST OF THE WORLD COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2019-2026 ($ MILLION)
  • 28. REST OF THE WORLD COVID-19 DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL COVID-19 DIAGNOSTICS MARKET SHARE BY TYPE, 2019 VS 2026 (%)
  • 2. GLOBAL COVID-19 DIAGNOSTICS MARKET SHARE BY TECHNOLOGY, 2019 VS 2026 (%)
  • 3. GLOBAL COVID-19 DIAGNOSTICS MARKET SHARE BY END-USER, 2019 VS 2026 (%)
  • 4. GLOBAL COVID-19 DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 5. US COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. CANADA COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. UK COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. FRANCE COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. GERMANY COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. ITALY COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. SPAIN COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. ROE COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. INDIA COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. CHINA COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. JAPAN COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. REST OF ASIA-PACIFIC COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)
  • 17. REST OF THE WORLD COVID-19 DIAGNOSTICS MARKET SIZE, 2019-2026 ($ MILLION)